UNSPSC 85641619: Revision of infusion device in upper extremity subcutaneous tissue and fascia, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of infusion device in upper extremity subcutaneous tissue and fascia, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JWVX3Z

UNSPSC 85641619 Revision of infusion device in upper extremity subcutaneous tissue and fascia, external approach is a Commodity code that does not align with the recent state and local contract opportunities posted under it. The code nominally describes a clinical medical procedure—revision of a subcutaneous infusion device in the upper extremity—yet the recent solicitations tracked against this code include independent medical evaluation services for pension disability determinations, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty medical care for detained youth, pharmacy benefit management, and temporary health professional staffing. None of these opportunities involve the insertion, repositioning, or revision of infusion devices or relate to the clinical procedure the code describes.

The mismatch suggests either a systemic classification error in how state and local procurement offices are tagging medical and health services opportunities, or that this code has been repurposed in practice to cover a broader family of health services contracting that falls outside its nominal scope. The recent activity does show a mix of issuing bodies—cities (Phoenix, Long Beach), state transportation and health agencies (Washington Department of Transportation, Santa Clara County Health System), county procurement offices (Harris County, Collier County), and independent pension boards—across Arizona, California, Washington, and Florida. However, because no recent opportunities reflect the actual work described in the code name, this code shows little relevant activity for vendors focused on infusion device revision or related clinical procedures. Firms considering pursuit should verify the code's applicability with the issuing procurement office before investing in proposal development.